Tank 1 – Cane 1

Source: Tank1_Cane1_-_Sheet1.csv  |  110 entries  |  Last updated: March 12, 2026

CANE BOX SLOT PRIMARY CELL NAME SECONDARY CELL NAME PASSAGE NUMBER QUANTITY DATE FROZEN BY CODE/COMMENTS
1 A 1 MCF10A 35 1/21/2013 JMD in DMEM-F12, 20% horse serum
1 A 2 MCF10A 35 21-Jan-13 JMD in DMEM-F12, 20% horse serum
1 A 5 mNG-Lamin A MDA-MB-231 - 11 10^6 4/2/2023 JC Do not carry in culture
more than 20P
1 A 6 MDA-MB-231 - P44.8 2x106 14-May-10 PG Do not carry in culture
more than 20P
1 A 7 MDA-MB-231 - P44.8 2x106 14-May-10 PG Do not carry in culture
more than 20P
1 A 8 MDA-MB-231 - P44.8 2x106 14-May-10 PG Do not carry in culture
more than 20P
1 A 9 MDA-MB-231 - P44.8 2x106 14-May-10 PG Do not carry in culture
more than 20P
1 A 10 MDA-MB-231 - P44.8 2x106 14-May-10 PG Do not carry in culture
more than 20P
1 A 11 ?? Do not carry in culture
more than 20P
1 A 12 MDA-MB-231 - P44.8 2x106 14-May-10 PG Do not carry in culture
more than 20P
1 A 13 MDA-MB-231 - P44.8 2x106 14-May-10 PG Do not carry in culture
more than 20P
1 A 14 MDA-MB-231 - P44.8 2x106 14-May-10 PG Do not carry in culture
more than 20P
1 A 15 MDA-MB-231 - P44.8 2x106 14-May-10 PG Do not carry in culture
more than 20P
1 A 16 MDA-MB-231-LaminA-NG MDA 10^6 1/15/2020 WZ
1 A 17 LLC-PKI (EGFP) 7 6/8/2015 JMD
1 A 18 RBL
1 A 19 RBL
1 A 20 ???? ????
1 A 21 mNG-Lamin A / mScarlet-Sec61 MDA-MB-231 4 10^6 11/22/2021 JC
1 A 22 LLC-PKI (EGFP) 7 6/8/2015 JMD
1 A 23 MDA-MB-231-LaminA-NG MDA 10^6 1/15/2020 WZ
1 A 24 LLC-PKI (EGFP) 7 6/8/2015 JMD
1 A 25 LLC-PKI (EGFP) 7 6/8/2015 JMD
1 B 1 mNeonGreen-Lamin A MDA-MB-231 11 10^6 4/2/2023 JC P7 from 1/15 freeze; Mycoplasma negative
1 B 2 MDA-MB-231-LaminA-NG MDA 10^6 1/15/2020 WZ
1 B 3 3T3-Swiss ATCC CCL-92 ATCC Vial 29-Aug-03 ATCC DMEM 500 ug/mL G418
1 B 4 LLC-PK1 ATCC CRL-139 ATCC Vial CL-101 29-Aug-03 ATCC
1 B 5 BHK-21 ATCC CCL-10 ATCC Vial 31-Dec-03 ATCC
1 B 6 ???? ????
1 B 7 mNG-Lamin A / mScarlet-Sec61 MDA-MB-231 4 10^6 11/22/2021 JC
1 B 8 mNG-Lamin A / mScarlet-Sec61 MDA-MB-231 4 10^6 11/22/2021 JC
1 B 9 mNG-Lamin A / mScarlet-Sec61 MDA-MB-231 4 10^6 11/22/2021 JC
1 B 10 MCF10A 35 1/21/2013 JMD in DMEM-F12, 20% horse serum
1 B 11 MDA-MB-231-LaminA-NG MDA 10^6 1/15/2020 WZ NIH 3T3 media +
800ug/ml G418
1 B 12 MDA-MB-231-LaminA-NG MDA 10^6 1/15/2020 WZ
1 B 13 HEK293T egfP-TfR Zipfel Lab 11/21/2016 Juan
1 B 14 HEK293T Zipfel Lab 7/12/2014
1 B 15 empty
1 B 16 RBL-PM-GFP 4/4/2004 Tobias
1 B 17 RBL-PM-GFP 4/4/2004 Tobias
1 B 18 RBL-PM-GFP 4/4/2004 Tobias
1 B 19 empty
1 B 20 3T3L1-lox 9 8/16/2012 JMD
1 B 21 HeLa 11 1x106 3/27/2007 PMG
1 B 22 LLC-PKI (EGFP) 7 6/8/2015 JMD
1 B 23 mNG-Lamin A / mScarlet-Sec61 MDA-MB-231 4 10^6 11/22/2021 JC
1 B 24 PK1 Baird 1/18/2001 PMG
1 B 25 T98G Baird 3/27/2007 PMG
1 C 1 HeLa 29 1x106 4/3/1999 JN
1 C 2 mNG-Lamin A / mScarlet-Sec61 MDA-MB-231 4 10^6 11/22/2021 JC
1 C 3 HeLa 29 1x106 4/3/1999 JN
1 C 4 HeLa 29 1x106 4/3/1999 JN
1 C 5 mNeonGreen-Lamin A MDA-MB-231 11 10^6 4/2/2023 JC P7 from 1/15 freeze; Mycoplasma negative
1 C 6 HeLa 29 1x106 4/3/1999 JN
1 7 HEK293T egfP-TfR 11/21/2016 Juan
1 8 U2OS from Philipp Iserman P+4 8/24/2014 JW
1 C 9 3T3L1 (Fischbach lab) 3 11/22/2011 JMD for transfection
1 C 10 3T3L1 (Fischbach lab) 3 11/22/2011 JMD for transfection
1 11 HEK293T egfP-TfR 11/21/2016 Juan
1 C 12 HEK293T egfP-TfR 11/21/2016 Juan MEM
1 C 13 HEK293T egfP-TfR 11/21/2016 Juan MEM
1 C 14 HEK293T egfP-TfR 10-Jan-14 Juan MEM
1 C 15 HEK293T egfP-TfR 10-Jan-14 Juan MEM
1 16 U2OS from Philipp Iserman P+4 8/24/2014 JW
1 C 20 MCF10A 32 8/16/2012 JMD
1 C 21 empty?
1 C 23 RBL-2H3 4 3x106 1/15/2008 PMG
1 C 24 RBL-2H3 4 3x106 1/15/2008 PMG
1 C 25 MCF10A 35 1/21/2013 JMD in DMEM-F12, 20% horse serum
1 D 1 MDA-MB-231 9 3/14/2011 AMD plate 1:3 or 1:2
1 D 2 MDA-MB-231 9 3/14/2011 AMD plate 1:3 or 1:2
1 D 3 MDA-MB-231 9 3/14/2011 AMD
1 D 4 MCF10A PSOC 16 12/23/2013 JMD
1 D 5 MCF10A PSOC 16 12/23/2013 JMD
1 D 6 u2os-clear cap 5 12/6/2020 bmw
1 D 7 u2os-clear cap 5 12/6/2020 bmw
1 D 8 MCF10CA1a KCI-metastatic 120 12/23/2013 JMD
1 D 9 MCF10CA1a KCI-metastatic 120 12/23/2013 JMD
1 D 10 MCF10A/MCF10CA1a mixture 16/120 0.3:0.1 12/23/2013 JMD
1 D 11 MCF10A/MCF10CA1a mixture 16/120 0.3:0.1 12/23/2013 JMD
1 D 12 ???? ???? 4 10^6 11/22/2021 JC
1 D 13 ???? u2os-clear cap 5 12/6/2020 bmw
1 D 14 RBL-2H3 u2os-clear cap 5 12/6/2020 bmw
1 D 15 RBL-2H3 u2os-clear cap 5 12/6/2020 bmw
1 D 16 RBL-2H3 4 10^6 11/22/2021 JC
1 D 23 SLC-44 Baird 2/27/2010 JP DMEM 10%FBS
rat epithelial
1 D 24 SLC-44 Baird 2/27/2010 JP DMEM 10%FBS
rat epithelial
1 D 25 SLC-44 Baird 2/27/2010 JP DMEM 10%FBS
rat epithelial
1 E 1 RBL Oliver P2/44 1x106 3/28/1999 RL
1 E 2 RBL Oliver P2/44 1x106 3/28/1999 RL
1 E 3 RBL Oliver P2/44 1x106 3/28/1999 RL
1 E 4 y 36 1/13/2011 JMD
1 E 5 PCNA LLC-PK1 9/5/2013 VL No G418 in freezing medium but needed for growth medium. Contact Abdullah Ozer (ao223) for passage number and details.
1 E 6 MDA-MB-231 36 1/13/2011 JMD
1 E 7 PC12 19 1x106 4/8/1999 JN super adherent
1 E 8 PC12 19 1x106 4/8/1999 JN super adherent
1 E 9 MCF-10AT EGFP-H2B 40-2 1/1/2013 JP Weaver Lab UCSF (Matt Paszek)
1 E 11 PCNA LLC-PK1 9/5/2013 VL No G418 in freezing medium but needed for growth medium. Contact Abdullah Ozer (ao223) for passage number and details.
1 E 12 3T3Swiss ATCC CCL-92 6 1x106 11/11/2002 KH
1 E 13 3T3Swiss ATCC CCL-92 6 1x106 11/11/2002 KH
1 E 14 3T3Swiss ATCC CCL-92 6 1x106 11/11/2002 KH
1 E 15 3T3Swiss 0 6 1x106 11/11/2002 KH
1 E 16 MCF-10A 16/2 1/13/2011 JMD
1 E 19
1 E 20 MCF-10AT mCHERRY-EGFP-H2B highly ch fluo 40-7 5/10/2015 JP selected for 10% highest cherry fluo by flow cytometry
1 E 21 MCF-10AT mCHERRY-EGFP-H2B highly ch fluo 40-7 5/10/2015 JP selected for 10% highest cherry fluo by flow cytometry
1 E 22 MCF-10AT mCHERRY-EGFP-H2B highly ch fluo 40-7 5/10/2015 JP selected for 10% highest cherry fluo by flow cytometry
1 E 23 MCF-10AT mCHERRY-EGFP-H2B highly ch fluo 40-7 5/10/2015 JP selected for 10% highest cherry fluo by flow cytometry
1 E 24 MCF-10AT mCHERRY-EGFP-H2B highly ch fluo 40-7 5/10/2015 JP selected for 10% highest cherry fluo by flow cytometry
1 E 25 Hela 36 1x106 5/3/1999 JN